TELA Bio, Inc.
TELA
Rank in Stocks
#22916
TELA Bio, Inc., a commercial-stage medical technology company, focuses on... TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patientโs anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Share Price
$0.8201
Last synced: 2026-11-13
Market Cap
$47.31M
Change (1 day)
-4.64%
Change (1 year)
-17.93%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade TELA Bio, Inc. (TELA)
Category
Healthcare
Operating Margin for TELA Bio, Inc. (TELA)
Operating Margin as of November 2026 TTM: -42.56%
According to TELA Bio, Inc.'s latest financial reports, its current operating margin (TTM) is -42.56%. At the end of 2025 the company had an operating margin of -42.05%.
Operating Margin history for TELA Bio, Inc. from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -42.56% | 1.21% |
| 2025 | -42.05% | -14.58% |
| 2024 | -49.23% | -34.71% |
| 2023 | -75.40% | -19.94% |
| 2022 | -94.18% | -5.78% |
| 2021 | -99.96% | -27.97% |
| 2020 | -138.77% | 11.86% |
| 2019 | -124.06% | -42.27% |
| 2018 | -214.91% | -46.09% |
| 2017 | -398.68% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.36% |
US
|
|
| 18.08% | -100.42% |
IE
|
|
| 21.25% | -100.50% |
US
|
|
| 21.05% | -100.49% |
US
|
|
| 28.09% | -100.66% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about TELA Bio, Inc.'s operating margin
What is TELA Bio, Inc.'s operating margin?
TELA Bio, Inc.'s operating margin is -42.56%, as of Nov 2026.
What was TELA Bio, Inc.'s operating margin in 2025?
In 2025, TELA Bio, Inc.'s operating margin was -42.05%, compared with -49.23% in 2024.
How has TELA Bio, Inc.'s operating margin changed since 2020?
From 2020 to 2025, TELA Bio, Inc.'s operating margin was highest in 2025 (-42.05%) and lowest in 2020 (-138.77%).
How does TELA Bio, Inc.'s operating margin compare with similar companies?
TELA Bio, Inc.'s operating margin (-42.56%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.